IP Library Granted Patent US 11,584,917
Granted Patent B2
US 11,584,917 · App. 15/998,586 · Granted Feb 21, 2023

Chemically defined medium for the culture of cancer stem cell (CSC) containing cell populations

Inventor: Hagen Wieland (Heidelberg, DE)
Assignee: PROMOCELL GMBH
C12N5/0693C12N5/0062C12N5/0695C12N2500/05C12N2500/10C12N2500/14C12N2500/16C12N2500/22C12N2500/25C12N2500/32C12N2500/36C12N2500/38C12N2500/99C12N2501/11C12N2501/115C12N2501/148C12N2501/15C12N2501/235C12N2501/2306C12N2501/2308C12N2513/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,584,917
App. No.
15/998,586
Granted
Feb 21, 2023
Kind
B2
Abstract

The present invention relates to a chemically defined medium for eukaryotic cell culture, comprising water, at least one carbon source, one or more vitamins, one or more salts, one or more growth factors, one or more fatty acids, one or more buffer components, selenium and one or more further trace elements and its use in the culture of cancer stem cells, in particular tumorsphere culture of cancer stem cells.

Claims (38)

1. A chemically defined medium for 3D tumorsphere culture, comprising water, at least one carbon source, one or more vitamins, one or more salts, one or more fatty acids, one or more buffer components, and trace elements:

aluminum (Al), in a concentration in a range of 1.5 nM to 15 nM;

barium (Ba), in a concentration in a range of 1.5 nM to 15 nM;

bromine (Br), in a concentration in a range of 0.4 nM to 4 nM;

cadmium (Cd), in a concentration in a range of 4 nM to 40 nM;

cobalt (Co), in a concentration in a range of 1 nM to 10 nM;

chromium (Cr), in a concentration in a range of 0.5 nM to 5 nM;

germanium (Ge), in a concentration in a range of 2 nM to 20 nM;

iodine (I), in a concentration in a range of 0.25 nM to 2.5 nM;

fluorine (F), in a concentration in a range of 12 nM to 120 nM;

nickel (Ni), in a concentration in a range of 0.2 nM to 2 nM;

manganese (Mn), in a concentration in a range of 0.1 nM to 1 nM;

molybdenum (Mo), in a concentration in a range of 0.7 nM to 7 nM;

rubidium (Rb), in a concentration in a range of 4 nM to 40 nM;

selenium (Se) in a concentration in a range of 40 nM to 400 nM;

silver (Ag), in a concentration in a range of 0.3 nM to 3 nM;

silicon (Si), in a concentration in a range of 130 nM to 1.3 μM;

tin (Sn), in a concentration in a range of 0.1 nM to 1 nM;

vanadium (V), in a concentration in a range of 2 nM to 22 nM; and

zirconium (Zr), in a concentration in a range of 3.5 nM to 35 nM,

wherein the medium is serum-free.

2. The chemically defined cell culture medium of claim 1 , wherein the chemically defined cell culture medium does not comprise any growth factor.

3. The chemically defined cell culture medium of claim 1 , comprising one or more growth factors.

4. The chemically defined medium according to claim 3 , wherein the one or more growth factors are selected from the group consisting of epidermal growth factor (EGF), basic fibroblast growth factor (bFGF), transforming growth factor (TGF), interleukin 6 (IL-6), interleukin 8 (IL-8), and leukemia inhibitory factor (LIF).

5. The chemically defined medium according to claim 4 , wherein the chemically defined cell culture medium comprises EGF and bFGF.

6. The chemically defined medium according to claim 1 , wherein the one or more fatty acids are selected from the group consisting of arachidonic acid, linolenic acid, linoleic acid, oleic acid, myristic acid, palmitic acid, and stearic acid, each in a concentration sufficient to support cancer stem cell proliferation and/or maintenance.

7. The chemically defined medium according to claim 6 , comprising at least two of the fatty acids.

8. The chemically defined medium according to claim 7 , comprising at least three of the fatty acids.

9. The chemically defined medium according to claim 1 , further comprising at least one surfactant.

10. The chemically defined medium according to claim 9 , comprising two nonionic surfactants polysorbate 80 and Poloxamer 188.

11. The chemically defined medium according to claim 9 , wherein the surfactant is a nonionic surfactant selected from the group consisting of polysorbates and Poloxamer 188.

12. The chemically defined medium according to claim 1 , further comprising insulin, transferrin, and/or albumin, each in a concentration sufficient to support cancer stem cell proliferation and/or maintenance.

13. The chemically defined medium according to claim 1 , wherein the buffer components are selected from the group consisting of HEPES, inorganic bicarbonate, inorganic phosphate, and 3-(N-Morpholino)propanesulfonic acid (MOPS).

14. The chemically defined medium according to claim 1 , comprising at least three buffer components.

15. The chemically defined medium according to claim 1 , further comprising cholesterol and/or tocopherol acetate.

16. A method of culturing cancer stem cells, comprising culturing cancer stem cells in the chemically defined medium according to claim 1 .

17. The method according to claim 16 , wherein the culturing of cancer stem cells is performed as 3D suspension culture.

18. A cell culture system, comprising cancer cells, in particular cancer stem cells, and a chemically defined medium according to claim 1 .

Assignments (2)
CHANGE OF NAME Recorded Feb 12, 2020
From: PROMOCELL BIOSCIENCE ALIVE GMBH BIOMEDIZINISCHE PRODUKTE
To: PROMOCELL GMBH
Reel/Frame 053502/0525 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2019
From: WIELAND, HAGEN
To: PROMOCELL BIOSCIENCE ALIVE GMBH BIOMEDIZINISCHE PRODUKTE
Reel/Frame 048467/0694 →
Priority Claims (1)
EP 16156163 · Feb 17, 2016 · regional
Continuity (1)
Related Publication 20190153396A1 · May 23, 2019